Grauer & Weil logo

Grauer & Weil

GRAUWEIL NSE

Key Fundamentals

MicrocapCommodity ChemicalsChemicals
Market Cap
₹3,415 Cr
Volatility
Moderate
P/E Ratio
21.42
EBITDA
₹243 Cr
Return on Equity
15.16%
Debt to Equity
0.01
Book Value
₹23.86
52W High
₹87.4
52W Low
₹62.09

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company is almost debt free.

Growth Rate

Revenue Growth
5.07% lower than 3Y
Net Income Growth
4.33% lower than 3Y
Cash Flow Change
5.44% higher than 3Y
ROE
-9.44% lower than 3Y
ROCE
-9.73% higher than 3Y
EBITDA Margin (Avg.)
-1.46% higher than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 69d ago
AI opinion · based on fundamentals
Risk medium

Grauer & Weil (India) Ltd is a nearly debt-free specialty chemicals and surface finishing company with a market cap of ₹3,695 Cr trading at a PE of 23x. The company has delivered consistent ROE of 16-18% over the past decade but is experiencing a slowdown in sales growth (TTM at 5%) and a significant deterioration in working capital efficiency.

Bull Case 7
  • Company is almost debt free, giving it significant financial flexibility and resilience during downturns
  • Consistent ROE track record of 16-18% over 3, 5, and 10-year periods indicates disciplined capital allocation
  • Compounded profit growth of 20% over 5 years outpaces sales growth of 14%, reflecting improving margins and operating leverage
  • 10-year stock CAGR of 18% demonstrates sustained long-term value creation for shareholders
  • Price-to-book ratio of 3.49x is reasonable for a debt-free company delivering 16% ROE consistently
  • 10-year compounded sales growth of 11% shows the company has scaled revenues meaningfully over a full business cycle
  • Dividend yield of 0.6% provides a modest income floor while the company retains earnings for growth
Bear Case 8
  • Stock has declined 20% over the past 1 year, significantly underperforming broader markets
  • Working capital days have nearly doubled from 53.6 days to 94.7 days, indicating deteriorating cash conversion and potential inventory or receivables stress
  • TTM sales growth has decelerated sharply to just 5% compared to 14% over 5 years and 11% over 10 years
  • ROE has dipped to 16% in the last year from 18% over 3 years, suggesting early signs of return compression
  • TTM profit growth of only 7% is well below the 5-year CAGR of 20%, showing a marked deceleration in earnings momentum
  • 3-year sales CAGR of just 7% compared to 5-year CAGR of 14% indicates the growth slowdown is a multi-quarter trend, not a one-off
  • PE of 23x may not be justified if the current single-digit growth trajectory persists, as it prices in higher growth expectations
  • Small market cap of ₹3,695 Cr in the commodities sector exposes the company to higher cyclical and liquidity risks

This is AI-generated analysis, not financial advice. Do your own due diligence.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
200
250
285
333
264
255
275
340
253
291
291
355
299
Expenses
152
202
230
294
200
212
222
311
201
248
252
296
251
Operating Profit
48
49
55
39
64
43
52
30
53
43
39
59
48
OPM %
24%
20%
19%
12%
24%
17%
19%
9%
21%
15%
13%
17%
16%
Other Income
6
7
9
8
8
14
12
12
13
11
12
13
12
Interest
0
0
0
3
0
0
1
2
1
0
0
1
1
Depreciation
5
5
5
5
5
6
6
6
6
6
6
6
6
PBT
48
51
58
39
67
51
58
34
58
48
44
65
54
Tax %
23%
26%
26%
26%
24%
26%
26%
25%
25%
20%
26%
24%
26%
Net Profit
37
37
43
29
51
38
43
26
44
39
32
50
40
EPS in Rs
0.81
0.83
0.94
0.64
1.12
0.83
0.95
0.57
0.96
0.85
0.71
1.09
0.88
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
409
413
432
497
600
618
605
768
981
1,068
1,133
1,190
1,236
Expenses
333
335
346
400
494
521
505
655
825
877
944
996
1,047
Operating Profit
76
78
86
98
106
97
101
114
156
191
189
194
189
OPM %
19%
19%
20%
20%
18%
16%
17%
15%
16%
18%
17%
16%
15%
Other Income
1
2
4
10
5
20
15
16
18
31
47
50
49
Interest
14
10
3
3
2
3
3
3
3
5
4
4
2
Depreciation
16
14
14
15
15
19
18
20
20
21
22
24
25
PBT
46
56
73
91
94
95
94
107
152
196
210
216
211
Tax %
28%
24%
26%
30%
32%
21%
27%
26%
26%
25%
25%
24%
—
Net Profit
33
42
54
64
64
76
69
79
113
146
157
164
160
EPS in Rs
0.74
0.93
1.2
1.41
1.41
1.67
1.52
1.74
2.49
3.23
3.47
3.62
3.53
Div. Payout %
15%
15%
17%
21%
21%
15%
16%
19%
16%
8%
14%
28%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
23
23
23
23
23
23
23
23
23
23
45
45
Reserves
194
228
278
331
379
422
491
560
657
783
894
1,036
Borrowings
68
27
20
7
21
23
22
25
24
27
12
15
Other Liabilities
125
119
133
146
159
174
214
217
251
292
334
349
Total Liabilities
410
397
454
507
581
642
750
824
954
1,124
1,286
1,445
Fixed Assets
216
210
212
206
231
241
238
247
244
243
254
277
CWIP
0
0
0
0
3
1
4
1
3
14
27
37
Investments
2
1
1
3
1
0
0
1
17
49
71
443
Other Assets
192
186
241
297
346
399
508
576
690
817
934
688
Total Assets
410
397
454
507
581
642
750
824
954
1,124
1,286
1,445
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
55
77
87
71
33
84
117
44
114
160
144
152
Investing
-9
-8
-54
-61
-13
-53
-43
-17
-116
-109
-120
-184
Financing
-46
-62
-10
-25
-2
-36
-3
-15
-19
-20
-42
-28
Net Cash Flow
0
8
23
-14
17
-5
71
12
-21
31
-19
-60
Free Cash Flow
45
69
72
62
-12
62
102
22
95
128
105
100
CFO/OP
83
114
120
94
63
110
132
72
98
107
105
98
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
80
70
63
65
68
67
77
62
68
63
64
54
Inventory Days
120
115
118
100
106
126
108
121
83
90
98
112
Days Payable
67
68
82
81
68
95
110
91
77
86
90
99
Cash Conversion Cycle
133
117
99
83
106
99
75
92
75
68
72
67
Working Capital Days
26
50
38
49
56
57
36
49
43
34
32
27
ROCE %
21%
24%
25%
27%
26%
20%
19%
19%
24%
26%
23%
21%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Grauer & Weil insights

64 extracted metrics + investor summaries across FY07–FY26.

Log in — free

Shareholding Pattern

DIIs0.05%Promot.69.04%FIIs0.35%Others7.36%Public23.19%As ofJun 2026

Documents

Frequently Asked Questions about Grauer & Weil

What does Grauer & Weil (India) Ltd do?
Incorporated in 1957, Grauer & Weil (India) Ltd manufactures and sells Surface Finishings besides being in Engineering and Mall business[1]
Where is Grauer & Weil (India) Ltd (GRAUWEIL) listed?
Grauer & Weil (India) Ltd trades as GRAUWEIL on the NSE and under code 505710 on the BSE.
Which sector does Grauer & Weil (India) Ltd belong to?
Grauer & Weil (India) Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the market capitalisation of Grauer & Weil (India) Ltd?
Grauer & Weil (India) Ltd has a market capitalisation of ₹3,415 Cr, which places it in the Small Cap band.
What is the PE ratio of Grauer & Weil (India) Ltd?
Grauer & Weil (India) Ltd trades at a PE ratio of 21.42, against a book value of ₹23.86 per share.
What is the 52-week high and low of Grauer & Weil (India) Ltd?
Over the last 52 weeks Grauer & Weil (India) Ltd has traded between ₹62.09 and ₹87.4.
Does Grauer & Weil (India) Ltd pay dividends?
Grauer & Weil (India) Ltd has a dividend yield of 0.65%.
What is the Return on Equity (ROE) of Grauer & Weil (India) Ltd?
Grauer & Weil (India) Ltd reported a return on equity of 15.16%. Its debt-to-equity ratio is 0.01.

Company Information

Incorporated in 1957, Grauer & Weil (India) Ltd manufactures and sells Surface Finishings besides being in Engineering and Mall business[1]

Website growel.com
CEO Mr. Umeshkumar N. More
Employees 964
Listed 2026-04-20
Face Value ₹ 1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GRAUWEIL.md for Grauer & Weil (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List